317 related articles for article (PubMed ID: 33488518)
1. Progressive Shifts in the Gut Microbiome Reflect Prediabetes and Diabetes Development in a Treatment-Naive Mexican Cohort.
Diener C; Reyes-Escogido ML; Jimenez-Ceja LM; Matus M; Gomez-Navarro CM; Chu ND; Zhong V; Tejero ME; Alm E; Resendis-Antonio O; Guardado-Mendoza R
Front Endocrinol (Lausanne); 2020; 11():602326. PubMed ID: 33488518
[TBL] [Abstract][Full Text] [Related]
2. The gut microbiome and type 2 diabetes status in the Multiethnic Cohort.
Maskarinec G; Raquinio P; Kristal BS; Setiawan VW; Wilkens LR; Franke AA; Lim U; Le Marchand L; Randolph TW; Lampe JW; Hullar MAJ
PLoS One; 2021; 16(6):e0250855. PubMed ID: 34161346
[TBL] [Abstract][Full Text] [Related]
3. Changes in the type 2 diabetes gut mycobiome associate with metformin treatment across populations.
Van Syoc E; Nixon MP; Silverman JD; Luo Y; Gonzalez FJ; Elbere I; Klovins J; Patterson AD; Rogers CJ; Ganda E
mBio; 2024 Jun; 15(6):e0016924. PubMed ID: 38767350
[TBL] [Abstract][Full Text] [Related]
4. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.
Alvarez-Silva C; Kashani A; Hansen TH; Pinna NK; Anjana RM; Dutta A; Saxena S; Støy J; Kampmann U; Nielsen T; Jørgensen T; Gnanaprakash V; Gnanavadivel R; Sukumaran A; Rani CSS; Færch K; Radha V; Balasubramanyam M; Nair GB; Das B; Vestergaard H; Hansen T; Mande SS; Mohan V; Arumugam M; Pedersen O
Genome Med; 2021 Mar; 13(1):37. PubMed ID: 33658058
[TBL] [Abstract][Full Text] [Related]
5. Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes.
Estrella MY; Daniel NR; Armando ED; Cristian PM; Aarón VJ; Paul SJ; David GV; Cristian MO; de Lourdes RM; Lola EM; Alberto AG; Osbaldo RA; Rodolfo GM
Sci Rep; 2024 Apr; 14(1):9678. PubMed ID: 38678119
[TBL] [Abstract][Full Text] [Related]
6. Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: A hypothesis.
Maniar K; Moideen A; Bhattacharyya R; Banerjee D
Med Hypotheses; 2017 Jul; 104():117-120. PubMed ID: 28673568
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiome encoded purine and amino acid pathways present prospective biomarkers for predicting metformin therapy efficacy in newly diagnosed T2D patients.
Elbere I; Orlovskis Z; Ansone L; Silamikelis I; Jagare L; Birzniece L; Megnis K; Leskovskis K; Vaska A; Turks M; Klavins K; Pirags V; Briviba M; Klovins J
Gut Microbes; 2024; 16(1):2361491. PubMed ID: 38868903
[TBL] [Abstract][Full Text] [Related]
8. Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark.
Pinna NK; Anjana RM; Saxena S; Dutta A; Gnanaprakash V; Rameshkumar G; Aswath S; Raghavan S; Rani CSS; Radha V; Balasubramanyam M; Pant A; Nielsen T; Jørgensen T; Færch K; Kashani A; Silva MCA; Vestergaard H; Hansen TH; Hansen T; Arumugam M; Nair GB; Das B; Pedersen O; Mohan V; Mande SS
Genome Med; 2021 Mar; 13(1):36. PubMed ID: 33658065
[TBL] [Abstract][Full Text] [Related]
9. Metformin Reduces Blood Glucose in Treatment-Naive Type 2 Diabetes by Altering the Gut Microbiome.
He D; Han H; Fu X; Liu A; Zhan Y; Qiu H; Ma L; Zhang X; Wang X
Can J Diabetes; 2022 Mar; 46(2):150-156. PubMed ID: 35148952
[TBL] [Abstract][Full Text] [Related]
10. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiome Composition and Serum Metabolome Profile Among Individuals With Spinal Cord Injury and Normal Glucose Tolerance or Prediabetes/Type 2 Diabetes.
Li J; Morrow C; Barnes S; Wilson L; Womack ED; McLain A; Yarar-Fisher C
Arch Phys Med Rehabil; 2022 Apr; 103(4):702-710. PubMed ID: 34126067
[TBL] [Abstract][Full Text] [Related]
13. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug.
Wu H; Esteve E; Tremaroli V; Khan MT; Caesar R; Mannerås-Holm L; Ståhlman M; Olsson LM; Serino M; Planas-Fèlix M; Xifra G; Mercader JM; Torrents D; Burcelin R; Ricart W; Perkins R; Fernàndez-Real JM; Bäckhed F
Nat Med; 2017 Jul; 23(7):850-858. PubMed ID: 28530702
[TBL] [Abstract][Full Text] [Related]
14. Associations between Diet, the Gut Microbiome, and Short-Chain Fatty Acid Production among Older Caribbean Latino Adults.
Maldonado-Contreras A; Noel SE; Ward DV; Velez M; Mangano KM
J Acad Nutr Diet; 2020 Dec; 120(12):2047-2060.e6. PubMed ID: 32798072
[TBL] [Abstract][Full Text] [Related]
15. Design of a cluster-randomized trial of the effectiveness and cost-effectiveness of metformin on prevention of type 2 diabetes among prediabetic Mexican adults (the PRuDENTE initiative of Mexico City).
Rodríguez LA; Barquera S; Aguilar-Salinas CA; Sepúlveda-Amor J; Sánchez-Romero LM; Denova-Gutiérrez E; Balderas N; Moreno-Loaeza L; Handley MA; Basu S; López-Arellano O; Gallardo-Hernández A; Schillinger D
Contemp Clin Trials; 2020 Aug; 95():106067. PubMed ID: 32580032
[TBL] [Abstract][Full Text] [Related]
16. Analyzing Type 2 Diabetes Associations with the Gut Microbiome in Individuals from Two Ethnic Backgrounds Living in the Same Geographic Area.
Balvers M; Deschasaux M; van den Born BJ; Zwinderman K; Nieuwdorp M; Levin E
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579166
[TBL] [Abstract][Full Text] [Related]
17. Dysbiosis signatures of gut microbiota and the progression of type 2 diabetes: a machine learning approach in a Mexican cohort.
Neri-Rosario D; Martínez-López YE; Esquivel-Hernández DA; Sánchez-Castañeda JP; Padron-Manrique C; Vázquez-Jiménez A; Giron-Villalobos D; Resendis-Antonio O
Front Endocrinol (Lausanne); 2023; 14():1170459. PubMed ID: 37441494
[TBL] [Abstract][Full Text] [Related]
18. Impact of intensive lifestyle intervention on gut microbiota composition in type 2 diabetes: a
Wei S; Brejnrod AD; Trivedi U; Mortensen MS; Johansen MY; Karstoft K; Vaag AA; Ried-Larsen M; Sørensen SJ
Gut Microbes; 2022; 14(1):2005407. PubMed ID: 34965188
[TBL] [Abstract][Full Text] [Related]
19. Response of gut microbiota in type 2 diabetes to hypoglycemic agents.
Zhang F; Wang M; Yang J; Xu Q; Liang C; Chen B; Zhang J; Yang Y; Wang H; Shang Y; Wang Y; Mu X; Zhu D; Zhang C; Yao M; Zhang L
Endocrine; 2019 Dec; 66(3):485-493. PubMed ID: 31410749
[TBL] [Abstract][Full Text] [Related]
20. Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot study.
Gravdal K; Kirste KH; Grzelak K; Kirubakaran GT; Leissner P; Saliou A; Casèn C
BMC Endocr Disord; 2023 Aug; 23(1):179. PubMed ID: 37605183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
